HFXE ETF Analysis

このページは英語の原文からAIによって機械翻訳されています。英語版が正式なものです。英語版を読む

情報提供のみを目的としています。投資助言ではありません。

クイックアンサー

In the stored portfolio snapshot dated Mar 15, 2026, the largest listed holding is Nestle SA (NESN) at 4.02%.

HFXE ETF — Price, Holdings & Analysis

ETF概要

HFXE provides targeted exposure to a select group of European companies, distinguishing itself through its highly. This approach contrasts with more diversified European equity ETFs, which typically hold hundreds of stocks. The fund's strategy centers on investing in established, large-cap companies, as evidenced by its top holdings in Nestle SA (4.02%), Roche Holding AG (3.10%), and Novartis AG (2.37%). These companies represent a mix of consumer staples and healthcare, indicating a potential focus on stable, dividend-paying stocks. The inclusion of technology companies like ASML Holding NV (1.68%) and SAP SE (1.58%) suggests a blend of traditional and growth-oriented sectors. Investors seeking concentrated exposure to leading European brands may find HFXE appealing, but should be aware of the increased risk associated with a less diversified portfolio. Past performance does not guarantee future results.

リスク指標

HFXE's introduces a significant level of concentration risk. A downturn in any of its top holdings could have a disproportionately large impact on the fund's overall performance. The fund's sector allocation also contributes to its risk profile, with a notable emphasis on consumer staples and healthcare. While these sectors are generally considered defensive, they may underperform during periods of strong economic growth. With a beta of 0.91, HFXE exhibits slightly lower volatility compared to the broader market. However, the concentrated nature of the fund could amplify its price swings relative to more diversified benchmarks. Investors should carefully consider their risk tolerance and investment horizon before investing in HFXE. Past performance does not guarantee future results.

ベータ: 0.91

HFXEは何を保有していますか？

銘柄	比率
Nestle SA (NESN)	4.02%
Roche Holding AG Dividend Right Cert. (ROG)	3.10%
Novartis AG (NOVN)	2.37%
AstraZeneca PLC (AZN.L)	1.79%
ASML Holding NV (ASML)	1.68%
SAP SE (SAP.DE)	1.58%
Novo Nordisk A/S B (NOVO B)	1.39%
Sanofi SA (SAN.PA)	1.36%
LVMH Moet Hennessy Louis Vuitton SE (MC.PA)	1.34%
GlaxoSmithKline PLC (GSK.L)	1.30%

保有銘柄と比率は2026年3月15日時点。このファンドデータは45日以上前のものです。最新の保有銘柄は発行体でご確認ください。

配当利回り

2.27%

よくある質問

What is HFXE and what does it track?

HFXE is an exchange-traded fund (ETF) that provides concentrated exposure to a select group of European equities. Unlike broad-based European equity ETFs, focusing on large-cap, well-established businesses.

The fund's top holdings include names like Nestle SA, Roche Holding AG, and Novartis AG, reflecting a bias towards stable, dividend-paying stocks.

What are the top holdings in HFXE?

HFXE's top holdings reflect its concentrated investment strategy, with a significant portion of its assets allocated to a small number of companies.

As of 2026-03-15, the top three holdings in HFXE are Nestle SA (4.02%), Roche Holding AG (3.10%), and Novartis AG (2.37%).

Is HFXE a good long-term investment?

Whether HFXE is a suitable long-term investment depends on an individual investor's specific circumstances and risk tolerance. The fund's European equities offers the potential for higher returns, but also carries a greater degree of risk compared to more diversified strategies.

HFXE's dividend yield of 2.27% may appeal to income-seeking investors.

How does HFXE compare to similar ETFs?

HFXE distinguishes itself from similar European equity ETFs through its highly. Most European equity ETFs hold hundreds of stocks, providing broader diversification.

HFXE's concentrated approach may lead to higher returns if its selected companies outperform, but it also increases the risk of underperformance if those companies struggle.

Does HFXE pay dividends?

Yes, HFXE distributes dividends to its shareholders. As of 2026-03-15, HFXE has a dividend yield of 2.27%. This means that for every $100 invested in HFXE, investors can expect to receive approximately $2.27 in dividend income annually.

The dividend yield can fluctuate over time depending on the fund's underlying holdings and market conditions.

免責事項：このコンテンツは情報提供のみを目的としており、投資助言を構成するものではありません。常に独自の調査を行い、ファイナンシャルアドバイザーにご相談ください。

データは情報提供のみを目的として提供されています。

本ページは機械が作成しており、1ページずつの人手レビューは行っていません。編集上の管理は仕組みとして行っています（ルールと出典を点検し、個々のページは点検していません）。